Format

Send to

Choose Destination
J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):137-145. doi: 10.1136/jnnp-2016-313300. Epub 2016 Sep 26.

Neurodegeneration in multiple sclerosis and neuromyelitis optica.

Author information

1
Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
2
Center for Brain Research, Medical University of Vienna, Vienna, Austria.

Abstract

Multiple sclerosis (MS) and neuromyelitis optica (NMO) are autoimmune demyelinating diseases of the central nervous system (CNS), having distinct immunological and pathological features. They have two pathogenic components, 'inflammation' and 'neurodegeneration', with different degrees of severity and pathogenetic mechanisms. The target antigen of autoimmunity in NMO is the water channel aquaporin-4 (AQP4), and antibodies directed against this antigen result in astrocyte damage. MS is a disease primarily affecting myelin and oligodendrocytes, but thus far, no MS-specific autoantigen has been identified. The distinct inflammatory processes in these diseases may trigger cascades of events leading to disease-specific neurodegeneration. Damage of the CNS tissue appears to be amplified by mechanisms that are in part shared by the two conditions and involve oxidative burst activation in microglia/macrophages, mitochondrial damage and axonal energy failure, Wallerian degeneration and meningeal inflammation. However, they appear to differ regarding the nature of the inflammatory response, the type and extent of cortical injury, and the type of astrocyte reaction and damage. Here, we provide a detailed comparison of the pathology between MS and NMO, which may help to define shared and disease-specific mechanisms of neurodegeneration in these diseases.

KEYWORDS:

MULTIPLE SCLEROSIS; NEUROIMMUNOLOGY; NEUROPATHOLOGY

PMID:
27671902
DOI:
10.1136/jnnp-2016-313300
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center